Exchange Traded Concepts LLC Acquires 975 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Exchange Traded Concepts LLC boosted its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 4.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 23,776 shares of the company’s stock after acquiring an additional 975 shares during the quarter. Exchange Traded Concepts LLC’s holdings in Prestige Consumer Healthcare were worth $1,857,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the business. Boston Trust Walden Corp bought a new position in Prestige Consumer Healthcare in the 3rd quarter valued at $41,785,000. Allspring Global Investments Holdings LLC grew its stake in Prestige Consumer Healthcare by 19.3% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,575,170 shares of the company’s stock valued at $113,570,000 after purchasing an additional 255,045 shares during the period. Wellington Management Group LLP bought a new position in Prestige Consumer Healthcare in the 3rd quarter valued at $6,342,000. Millennium Management LLC grew its stake in Prestige Consumer Healthcare by 565.1% in the 2nd quarter. Millennium Management LLC now owns 101,218 shares of the company’s stock valued at $6,969,000 after purchasing an additional 86,000 shares during the period. Finally, Barclays PLC grew its stake in Prestige Consumer Healthcare by 346.3% in the 3rd quarter. Barclays PLC now owns 92,444 shares of the company’s stock valued at $6,665,000 after purchasing an additional 71,730 shares during the period. Institutional investors own 99.95% of the company’s stock.

Insider Buying and Selling

In related news, insider William P’pool sold 8,987 shares of the stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $81.85, for a total transaction of $735,585.95. Following the sale, the insider now owns 20,058 shares of the company’s stock, valued at approximately $1,641,747.30. This represents a 30.94 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Ronald M. Lombardi sold 10,875 shares of the stock in a transaction dated Tuesday, November 19th. The stock was sold at an average price of $82.60, for a total value of $898,275.00. Following the sale, the chief executive officer now directly owns 320,952 shares in the company, valued at $26,510,635.20. This trade represents a 3.28 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 38,810 shares of company stock valued at $3,187,300. Corporate insiders own 1.60% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on PBH shares. Sidoti downgraded Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price objective for the company. in a research note on Monday, December 9th. StockNews.com upgraded Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research note on Friday. Raymond James upgraded Prestige Consumer Healthcare to a “moderate buy” rating in a research note on Thursday, December 19th. Finally, DA Davidson reiterated a “buy” rating and set a $95.00 price target on shares of Prestige Consumer Healthcare in a research note on Monday, November 11th. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, Prestige Consumer Healthcare currently has an average rating of “Moderate Buy” and an average price target of $85.25.

Prestige Consumer Healthcare Stock Up 0.1 %

PBH stock opened at $76.79 on Monday. The stock has a fifty day moving average of $80.08 and a 200-day moving average of $74.93. The company has a market capitalization of $3.79 billion, a price-to-earnings ratio of 18.68, a PEG ratio of 2.17 and a beta of 0.51. The company has a debt-to-equity ratio of 0.61, a quick ratio of 2.10 and a current ratio of 3.56. Prestige Consumer Healthcare Inc. has a fifty-two week low of $60.00 and a fifty-two week high of $86.36.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings data on Thursday, November 7th. The company reported $1.09 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $1.09. The business had revenue of $283.79 million for the quarter, compared to analysts’ expectations of $282.09 million. Prestige Consumer Healthcare had a return on equity of 12.23% and a net margin of 18.54%. The firm’s quarterly revenue was down .9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.07 EPS. As a group, equities research analysts predict that Prestige Consumer Healthcare Inc. will post 4.46 earnings per share for the current year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.